半岛bd体育手机客户端 说明
一般描述
A nonsteroidal anti-inflammatory drug (NSAID) that acts as a reversible and competitive inhibitor of cyclooxygenase 1 (COX-1) (IC50= 4.85 ?M). Inhibits COX-2 at higher concentrations (IC50= 223 ?M). Blocks aspirin inactivation of COX-1 (EC50antagonism of 200 ?M aspirin = 290 nM). Shown to reduce the total Aβ secretion (Amyloid β40 and 42) in human neuronal cells and offers neuroprotection against glutamate-, nitric oxide-, and superoxide-induced damage. Reported to activate peroxisome proliferator-activated receptors (PPAR) α and γ in both CV-1 and C3H10T1/2 cells (~100 ?M-500 ?M).
A nonsteroidal anti-inflammatory drug (NSAID) that acts as a reversible, competitive, non-selective cyclooxygenase (COX) inhibitor (IC50= 4.85 ?M for purified COX-1 and 223 ?M for purified COX-2). Also reported to inhibit COX-1 and COX-2 activity in intact bovine aortic endothelial cells (BAEC) (IC50= 7 ?M for COX-1 and 72.7 ?M for COX-2). Potently blocks aspirin inactivation of COX-1 (EC50antagonism of 200 ?M aspirin ~290 nM for ovine COX-1). Decreases the secretion of total Aβ (Amyloid β40&42) by human neuronal cells and offers neuroprotection against glutamate-, nitric oxide- and superoxide-induced damage. Activates peroxisome proliferator activated receptors α and γ in both CV-1 and C3H10T1/2 cells (~100 ?M - 500 ?M).
包装
1 g in Plastic ampoule
生化/生理作用
Primary Target
COX-1
Target IC50: 4.85 ?M against COX-1
Product competes with ATP.
Cell permeable: no
Reversible: yes
警告
Toxicity: Harmful (C)
重悬
Following reconstitution aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
其他说明
Asanuma, M., et al. 2001.J. Neurochem.76,1895.
Blasko, I., et al. 2001.Neurobiol. Dis.8,1094.
Ouellet, M., et al. 2001.Proc. Natl. Acad. Sci. USA98,14583.
Casper, D., et al. 2000.Neurosci. Lett.289,201.
Lambat, Z., et al. 2000.Metab. Brain Dis.15,249.
Lim, G.P., et al. 2000.J. Neurosci.20,5709.
Ogawa, O., et al. 2000.Eur. J. Pharmacol.408,137.
Wyss-Coray, T., and Mucke, L. 2000.Nat. Med.6,973.
Lehmann, J.M., et al. 1997.J. Biol. Chem.272,3406.
Boneburg, E.M., et al. 1996.J. Clin. Pharmacol.36,16S.
Mitchell, J.A., et al. 1994.Proc. Natl. Acad. Sci. USA90,11693.
法律信息
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
基本信息
| 经验(实验)分子式 | C13H18O2 |
| 分子量 | 206.28 |
| MDL编号 | MFCD00010393 |
半岛bd体育手机客户端 性质
| 质量水平 | 100 |
| 测定 | ≥98% (titration) |
| 形式 | solid |
| manufacturer/tradename | Calbiochem? |
| 储存条件 | OK to freeze protect from light |
| 颜色 | white |
| 溶解性 | ethanol: 1 mg/mL DMSO: 5 mg/mL |
| 运输 | ambient |
| 储存温度 | 10-30℃ |
| InChI | 1S/C13H18O2/c1-9(2)8-11-4-6-12(7-5-11)10(3)13(14)15/h4-7,9-10H,8H2,1-3H3,(H,14,15) |
| InChI key | HEFNNWSXXWATRW-UHFFFAOYSA-N |
安全信息
| 象形图 |  |
| 警示用语： | Warning |
| 危险声明 | H302 - H319 - H335 |
| 预防措施声明 | P261 - P264 - P270 - P271 - P301 + P312 - P305 + P351 + P338 |
| 危险分类 | Acute Tox. 4 Oral - Eye Irrit. 2 - STOT SE 3 |
| 靶器官 | Respiratory system |
| 储存分类代码 | 11 - Combustible Solids |
| WGK | WGK 3 |
Sigma-Aldrich
m.cnreagent.com
